INZY
Bank of New York Mellon’s Inozyme Pharma INZY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-155,695
| Closed | -$142K | – | 4182 |
|
|
2025
Q1 | $142K | Hold |
155,695
| – | – | ﹤0.01% | 3938 |
|
|
2024
Q4 | $431K | Sell |
155,695
-1
| -0% | -$3 | ﹤0.01% | 3579 |
|
|
2024
Q3 | $814K | Sell |
155,696
-35,200
| -18% | -$184K | ﹤0.01% | 3250 |
|
|
2024
Q2 | $851K | Buy |
190,896
+26,464
| +16% | +$118K | ﹤0.01% | 3282 |
|
|
2024
Q1 | $1.26M | Buy |
164,432
+6,417
| +4% | +$49.2K | ﹤0.01% | 3022 |
|
|
2023
Q4 | $673K | Buy |
158,015
+16,874
| +12% | +$71.9K | ﹤0.01% | 3388 |
|
|
2023
Q3 | $593K | Sell |
141,141
-563
| -0.4% | -$2.37K | ﹤0.01% | 3451 |
|
|
2023
Q2 | $789K | Buy |
141,704
+94,539
| +200% | +$527K | ﹤0.01% | 3334 |
|
|
2023
Q1 | $270K | Buy |
47,165
+26,922
| +133% | +$154K | ﹤0.01% | 3786 |
|
|
2022
Q4 | $21.3K | Hold |
20,243
| – | – | ﹤0.01% | 4345 |
|
|
2022
Q3 | $54K | Sell |
20,243
-1,655
| -8% | -$4.42K | ﹤0.01% | 4304 |
|
|
2022
Q2 | $105K | Sell |
21,898
-18,115
| -45% | -$86.9K | ﹤0.01% | 4215 |
|
|
2022
Q1 | $164K | Sell |
40,013
-1,183
| -3% | -$4.85K | ﹤0.01% | 4297 |
|
|
2021
Q4 | $281K | Buy |
41,196
+778
| +2% | +$5.31K | ﹤0.01% | 4125 |
|
|
2021
Q3 | $469K | Buy |
40,418
+3,872
| +11% | +$44.9K | ﹤0.01% | 3845 |
|
|
2021
Q2 | $623K | Buy |
36,546
+13,209
| +57% | +$225K | ﹤0.01% | 3664 |
|
|
2021
Q1 | $462K | Buy |
23,337
+1,988
| +9% | +$39.4K | ﹤0.01% | 3728 |
|
|
2020
Q4 | $440K | Buy |
21,349
+1,964
| +10% | +$40.5K | ﹤0.01% | 3678 |
|
|
2020
Q3 | $509K | Buy |
+19,385
| New | +$509K | ﹤0.01% | 3485 |
|